Tags : (ARGX-110)

Innovate and Massachusetts General Hospital Collaborates to Develop Larazotide for

Shots: The collaboration is focused on development of Larazotide for Alcoholic Liver Diseases (ALD), including severe alcoholic hepatitis Innovate will conduct an investor update on 17 Dec, 2018 for Larazotide, in celiac disease clinical program and NASH development strategy Larazotide (INN-202) is a synthetic eight amino acid peptide drug, completed P-II trial and expected to […]Read More